Evidence map›Paper›PMID 19100323›Full record

ArticleJournal of ethnopharmacology2009

Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats.

Rui-Xin Zhang, Arthur Yin Fan, An-Nan Zhou, Kamal D Moudgil, Zhong-Ze Ma, David Yue-Wei Lee, Harry H S Fong, Brian M Berman, Lixing Lao

Open access · greenAbstract read
In one paragraph

Article in Journal of ethnopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Diseases (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Anti-arthritic activity ofIranian journal of basic medical sciences · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-κB in a Rat Model of Rheumatoid Arthritis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  13. The Ethanolic Extract ofIranian journal of pharmaceutical research : IJPR · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
  18. Microarray analysis reveals the molecular basis of antiarthritic activity of huo-luo-xiao-ling dan.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Rui-Xin ZhangCenter for Integrative Medicine, School of Medicine, University of Maryland, 3rd Floor, James Kernan Hospital Man., 2200 Kernan Drive, Baltimore, MD 21207, USA.
Arthur Yin Fan
An-Nan Zhou
Kamal D Moudgil
Zhong-Ze Ma
David Yue-Wei Lee
Harry H S Fong
Brian M Berman
Lixing Lao
University of Maryland, Baltimore · USHarvard University · USMcLean Hospital · USUniversity of Illinois Chicago · USUniversity of Maryland Rehabilitation & Orthopaedic Institute · US

Funding

Scientific Analysis CoreP01AT002605 · NCCIH · UNIVERSITY OF MARYLAND BALTIMORE · PI BERMAN, BRIAN M · 2005 to 2009
$6.4M
NCCIH NIH HHS P01 AT002605
6 · The paper itself

Abstract

ethnopharmacological relevanceThe herbal formula Huo Luo Xiao Ling Dan (HLXL) and its modifications have been used in traditional Chinese medicine for about one hundred years to alleviate pain and inflammation.

aimTo investigate the effects of HLXL on complete Freund's adjuvant (CFA)-induced multiple-joint arthritis in rats. MATERIALS AND

methodsMale Lewis rats, 190-210 g, were immunized subcutaneously at the base of the tail with 200 microl of heat-killed Mycobacterium tuberculosis in mineral oil (5 mg/ml). HLXL (2.30 and 4.60 g/kg) or vehicle control (n=8 per group) was administered orally (i.g.) once a day between days 16 and 25 post-CFA injection. The rats were observed for signs of arthritis with arthritic changes (erythema, edema, induration) being scored on a scale of 0-4 of increasing severity using a standard scoring system. The maximum arthritis score per rat was 16. A plethysmometer was used to measure edema volume in each paw. Adverse effects of HLXL were monitored by closely observing the animals for unusual behavioral changes. Levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1beta) in local tissue were measured by enzyme-linked immunosorbent assay on day 25 post-CFA.

resultsHLXL significantly decreased arthritis scores between days 23-25 in the 2.30 g/kg group and 21-25 in the 4.60 g/kg group (p<0.05). It reduced paw edema on days 22 and 24 in the 2.30 g/kg group and on days 20, 22 and 24 in the 4.60 g/kg group compared to control (p<0.05). Local tissue TNF-alpha and IL-1beta levels on day 25 post-CFA injection were significantly (p<0.05) lower in rats treated with HLXL than in control rats. No observable adverse effects were found.

conclusionThe data suggest that HLXL produces significant anti-arthritic effects that may be mediated by suppressing pro-inflammatory cytokines, and it appears to be safe.

Indexed as

MagnoliopsidaPhytotherapyAnimalsArthritis, ExperimentalDrugs, Chinese HerbalEdemaFootFreund's AdjuvantInterleukin-1betaMalePlant ExtractsRatsRats, Inbred LewTumor Necrosis Factor-alphaDrugs, Chinese HerbalFreund's AdjuvantInterleukin-1betaPlant ExtractsTumor Necrosis Factor-alpha

Identifiers

PMID19100323
PMCPMC2818782
OpenAlexW2152985277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.